Service Providers
TB Coordinator: Diane Freedman, RN PHN - 775-785-4787
Email: dfreedman@washoecounty.us
New TB Regimen
- CDC guidelines, Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection (MMWR 2011; 60: 1650-1653).
- CDC press release
- Reference from the New England Journal of Medicine, December 8, 2011: Sterling TR, Villarino, ME, Borisov, AS et. al. "Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection."
- December 23, 2011 issue of Epi News
Tuberculosis is a Reportable Illness.
Please report tuberculosis (confirmed and suspected) to the Washoe County Health District, Communicable Disease Program. Phone: 775-328-2447 or Fax: 775-328-3764. Confidential case report - Communicable disease report (pdf)
How Can You Help Control TB?
- Identify test and treat. Actively identify and test your patients who are most likely to be infected with TB or who are at increased risk of developing TB if they are infected. Offer treatment to your patients with latent tuberculosis infection (LTBI) and encourage them to complete the full regime.
- Persons at risk for TB infection:
- Contacts to TB case - especially children under 5 years
- Foreign-born persons from endemic countries (China, India, Mexico, Phillipines, Vietnam)
- Persons who have lived in endemic countries
- Conditions that increase the risk of LTBI progressing to TB
- HIV infection - the strongest known risk factor
- Diabetes mellitus
- Immune system disorders
- Use of TNF - antagonists (infliximab, etanercept and adalimumab)
- Recent TB infection - the greatest risk for progression to TB is in the first 2 years after infection
- Recent immigration - persons from endemic countries who have been in the US for less than 5 years have a 4 times greater risk of developing TB than those who have been in the US more than 5 years
- Persons who are 10% or more below ideal body weight
- End stage renal disease
- Silicosis
- Gastrectomy/jejunoileal bypass
- Organ transplant
- Persons at risk for TB infection:
- Use DOT. Directly Observed Therapy is the gold standard of care for treating persons with TB disease. DOT is the most effective strategy for ensuring completion of treatment, preventing multi-drug resistant TB and preventing severe complications.
- Ask for assistance. The TBPCP coordinator, TB Case Managers and PHNs welcome your questions and referrals. We are delighted to share our knowledge and resources and extend consultation from our board-certified pulmonary specialists.
- Provide education for patients & health care providers. Order free CDC materials in stock at the local TB clinic or order online directly from the CDC.
TBPCP Staff
TBPCP Coordinator: Diane Freedman, RN PHN - 775-785-4787
TB Case Managers:
Judy Medved-Gonzalez, RN PHN - 775-785-4789
Joyce Minter, RN PHN - 775-785-4789
PHN Liaisons:
Homeless: Sally Fry-Woyciehowsky, RN PHN - 775-785-4789
Immigration: Diane Freedman, RN PHN - 775-785-4787
Infection Control: Judy Medved-Gonzalez, RN PHN - 775-785-4789
WC Detention Facility: Joyce Minter, RN PHN - 775-785-4789
TB/HIV: Judy Medved-Gonzalez, RN PHN - 775-785-4789
TBPCP Guidelines:
The following policy and protocols are intended as guides for community providers.
- CDC Publication "MMWR June 25, 2010/Vol. 59/No. RR-5: Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection – United States, 2010"
- Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005
- Latent TB Infection Treatment Protocol (PDF, 32.8 KB)
- Nevada State Health Division technical bulletin: Using QuantiFERON and Tuberculin Skin Test to Screen for TB (PDF, 202 KB)
- Nevada State Health Division technical bulletin: Using QuantiFERON and Tuberculin Skin Test to Screen for TB and Interpretation of Results (PDF, 245 KB)
- Pediatric Treatment Guidelines (PDF, 24.1 KB)
- Epi News - Technical Bulletin: Reporting Requirements Protocol Guidelines for Infection Control of Hospitalized TB Patients (PDF, 88.2 KB)
- TB Disease Protocol (PDF, 49.7 KB)
TB Resources:
- www.cdc.gov/tb/ - Up-to-date guidelines and recommendations from the Center for Disease Control and Prevention
- www.who.int/tb/en - Information on global TB from the World Health Organization
- www.stoptb.org - Information on the Global Stop TB Plan. Videos.
- www.lungusa.org - American Lung Association
- Nevada State Health Division
- www.findtbresources.org - TB training materials
- www.currytbcenter.ucsf.edu - Francis J. Curry National Tuberculosis Center - regional TB information and training opportunities, including on-line courses.
- www.currytbcenter.ucsf.edu/products/tbradiographic.cfm - Radiographic Manifestations of Tuberculosis: A Primer for Clinicians, Second Edition
- (877) 390-NOTB [(877) 390-6682] Francis J. Curry National Tuberculosis Center Warmline - Tuberculosis experts answer questions about Tuberculosis Monday-Friday, 8:30am - 4:30pm.
Epi-News Issues Featuring Tuberculosis
- 3/23/2012 - World TB Day March 24
- 12/23/2011 - LTBI 12 Dose Regimen
- 03/23/2011 - World TB Day 2011
- 03/23/2010 - World TB Day 2010
- 12/21/2009 - Reporting Requirements Protocol Guidelines for Infection Control of Hospitalized TB Patients
- 3/24/2009 - World TB Day 2009
- 3/21/2008 - World TB Day 2008
- 1/15/2008 - Tuberculosis - Adaptability through the centuries
- 7/27/2007 - A New Test for Tuberculosis - QuantiFERON®- TB Gold
- 3/17/2006 - World TB Day 2006
- 3/21/2005 - World TB Day 2005